Health In Tech Inc-A 2024年度报告

FORM 10-K ☐Annual Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2024 OR ☐Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from___________to___________ Commission File Number: 001-42449 Health In Tech, Inc.(Exact name of registrant as specified in its charter) Nevada87-3545722(State or other jurisdiction of(I.R.S. Employer incorporation or organization)Identification No.) Stuart, FL34994(Address of principal executive offices)(Zip Code) 888-373-0333(Registrant’s telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: Title of each classTrading Symbol(s)Name of each exchange on whichregisteredClass A common stock, par valueHITThe Nasdaq Stock Market LLC $0.001 per share Securities registered pursuant to section 12(g) of the Act: None Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the SecuritiesAct. Yes☐No☐ Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of theAct. Yes☐No☐ Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) ofthe Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrantwas required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes☐No☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to besubmitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or forsuch shorter period that the registrant was required to submit such files). Yes☐No☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer,a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,”“accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of theExchange Act. Large accelerated filer☐ Non-accelerated filer☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extendedtransition period for complying with any new or revised financial accounting standards provided pursuant to Section13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment ofthe effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.☐ If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financialstatements of the registrant included in the filing reflect the correction of an error to previously issued financialstatements.☐ Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis ofincentive-based compensation received by any of the registrant’s executive officers during the relevant recoveryperiod pursuant to §240.10D-1(b).☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes☐No☐ Aggregate market value of voting stock held by non-affiliates of the registrant as of June 30, 2024 was $0.00. TheRegistrant’s Class A common stock began trading on December 23, 2024. As of March 17, 2025, there were 42,914,870 shares of Class A common stock outstanding and 11,700,000 shares ofClass B common stock outstanding. None. TABLE OF CONTENTS Item 1Business1Item 1ARisk Factors13Item 1BUnresolved Staff Comments34Item 1CCybersecurity34Item 2Properties36Item 3Legal Proceedings36Item 4Mine Safety Disclosures36PART II Item 5Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases ofEquity Securities37Item 6[Reserved]37Item 7Management’s Discussion and Analysis of Financial Condition and Results of Operations38Item 7AQuantitative and Qualitative Disclosures About Market Risk49Item 8Consolidated Financial Statements and Supplementary Data49Item 9Changes in and Disagreements with Accountants on Accounting and Financial Disclosure49Item 9AControls and Procedures49Item 9BOther Information49Item 9CDisclosure Regarding Foreign Jurisdictions that Prevent Inspections49 Item 10Directors, Executive Officers and Corporate Governance50Item 11Executive Compensation55Item 12Security Ownership of Certain Beneficial Owners and Management and Related StockholderMatters62Item 13Certain Relationships and Related Transactions and Director Independence64Item 14Principal Accountant Fees and Services65 Item 15Exhibits and Financial Statement Schedules65Item 16Form 10-K Summary66 CERTAIN TERM